Search Videos and More
Leadless dual-chamber pacemaker is a leap forward for heart patients
About 3 million people in the U.S. live with a pacemaker, a battery-powered device implanted in the chest to help the heart beat at its proper rate. Each year, about 200,000 devices are implanted in the U.S. for patients who have bradycardia (slow heartbeat) or abnormal heart rhythms.New Findings Alter View of EGFR Signaling in Glioblastoma
Signaling pathway thought to be driving oncogenesis gets called into question.An Expanding View of Ataxia
A renowned clinical research program seeks new insights into ataxia and related disorders.The Power of An Integrated Spine Care Mission
Progress in joint replacement procedures has led to ever-shorter surgeries and broadened options, yet innovations in treating spine pathology – the leading cause of pain in adults the world over – has remained in the risk-averse shadows. Too often, these patients travel on diagnostic or treatment odysseys before receiving appropriate personalized treatment.From Hope to Help
Interventional psychiatry answers unmet needs in treatment-resistant depression.New AI tool may help detect early signs of dementia
UTSW-led study finds an automated speech analysis algorithm is able to recognize cognitive impairment in a Spanish-speaking population.New AI tool to detect possible metastatic breast cancer
By improving MRI sensitivity, a model developed by UT Southwestern could potentially eliminate unnecessary biopsiesTaking Robotic Surgery to the Next Level
From breast cancer to gastrointestinal tumors, UTSW faculty are shaping the future of robotic surgery.Integrating Academic Medicine into Community Oncology
Suzanne Cole, M.D., shares how her passion for community-based cancer care informed her strategy for improving patient recruitment in clinical trials.Expert Dermatology Care for Cancer Patients
The Oncodermatology Clinic at Simmons Cancer Center specializes in skincare for cancer patients, treating chemo rashes, post-surgery scarring and more common issues.Drug Developed by UTSW Spinoff Now Approved for Metastatic Kidney Cancer
The FDA has expanded its approval of belzutifan, a new kidney cancer drug, to treat metastatic renal cancer. Learn about UTSW’s role, from gene discovery to drug development.The Habenula: From Synaptic Dynamics to Mood Disorders
The Shabel Lab is at the forefront of investigating the role of the habenula in motivated behavior and mood disorders.